Royal Bank of Canada’s Scinai Immunotherapeutics SCNI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6972 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6916 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6901 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6935 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7066 |
|
|
2023
Q1 | – | Sell |
-25
| Closed | -$1K | – | 6894 |
|
|
2022
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 6601 |
|
|
2022
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 6569 |
|
|
2022
Q2 | $3K | Hold |
25
| – | – | ﹤0.01% | 6384 |
|
|
2022
Q1 | $4K | Hold |
25
| – | – | ﹤0.01% | 6846 |
|
|
2021
Q4 | $6K | Hold |
25
| – | – | ﹤0.01% | 6656 |
|
|
2021
Q3 | $6K | Hold |
25
| – | – | ﹤0.01% | 6565 |
|
|
2021
Q2 | $7K | Hold |
25
| – | – | ﹤0.01% | 6476 |
|
|
2021
Q1 | $10K | Hold |
25
| – | – | ﹤0.01% | 6313 |
|
|
2020
Q4 | $7K | Sell |
25
-11
| -31% | -$3.08K | ﹤0.01% | 5986 |
|
|
2020
Q3 | $141K | Buy |
36
+2
| +6% | +$7.83K | ﹤0.01% | 4302 |
|
|
2020
Q2 | $78K | Sell |
34
-1
| -3% | -$2.29K | ﹤0.01% | 4539 |
|
|
2020
Q1 | $27K | Buy |
35
+26
| +289% | +$20.1K | ﹤0.01% | 4926 |
|
|
2019
Q4 | $8K | Hold |
9
| – | – | ﹤0.01% | 5624 |
|
|
2019
Q3 | $5K | Hold |
9
| – | – | ﹤0.01% | 5392 |
|
|
2019
Q2 | $5K | Hold |
9
| – | – | ﹤0.01% | 5406 |
|
|
2019
Q1 | $5K | Hold |
9
| – | – | ﹤0.01% | 5315 |
|
|
2018
Q4 | $4K | Hold |
9
| – | – | ﹤0.01% | 5381 |
|
|
2018
Q3 | $5K | Hold |
9
| – | – | ﹤0.01% | 5664 |
|
|
2018
Q2 | $6K | Hold |
9
| – | – | ﹤0.01% | 5410 |
|
|
2018
Q1 | $5K | Buy |
+9
| New | +$5K | ﹤0.01% | 5324 |
|